What is the 13F Pro Quality Score for MLSS?

13F Pro ranks MILESTONE SCIENTIFIC INC. (MLSS) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View MLSS's current score at https://13fpro.ai/research/MLSS (free sign-up required for the full ranking).

Where does 13F Pro source MLSS data?

All MILESTONE SCIENTIFIC INC. fundamentals and ownership data come directly from SEC EDGAR. MILESTONE SCIENTIFIC INC. files with the SEC under CIK 855683. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is MLSS in?

MILESTONE SCIENTIFIC INC. (MLSS) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is MLSS research updated on 13F Pro?

MLSS's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

MILESTONE SCIENTIFIC INC.(MLSS)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 855683 MLSS stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $11.3M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

MLSS Stock Analysis & AI Quality Score

AI stock analysis and institutional research for MILESTONE SCIENTIFIC INC. (MLSS), a Healthcare sector company. MLSS is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $11.3m in revenue. Based on the latest XBRL financial filings (Q1 2026), MILESTONE SCIENTIFIC INC. reports quarterly revenue of $2.2M, net income of $-839.9K, free cash flow of $85.2K. Top institutional holders of MLSS by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT,, VANGUARD FIDUCIARY CO, based on the most recent SEC filings. MLSS trades on the NYSE exchange and files with the SEC under CIK 855683. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MLSS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MILESTONE SCIENTIFIC INC. directly from SEC EDGAR.

Revenue

Q1 2026

$2.2M

Net Income

Q1 2026

$-839.9K

Free Cash Flow

Q1 2026

$85.2K

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+4.0% YoY

$9.0MFY 2025

FY22 $8.8MFY23 $9.8MFY24 $8.6MFY25 $9.0M

Net Income

-21.4% YoY

$-5.7MFY 2025

FY22 $-8.7MFY23 $-6.9MFY24 $-4.7MFY25 $-5.7M

Operating Income

+15.7% YoY

$-5.7MFY 2025

FY22 $-8.8MFY23 $-7.1MFY24 $-6.8MFY25 $-5.7M

EPS (Diluted)

-16.7% YoY

$-0.07FY 2025

FY22 —FY23 —FY24 $-0.06FY25 $-0.07

Total Assets

-20.3% YoY

$7.8MFY 2025

FY22 $13.7MFY23 $11.4MFY24 $9.8MFY25 $7.8M

Op. Cash Flow

+0.1% YoY

$-2.9MFY 2025

FY22 $-6.0MFY23 $-5.3MFY24 $-2.9MFY25 $-2.9M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$9.0M +4.0%	$8.6M -12.2%	$9.8M +11.6%	$8.8M -14.5%	$10.3M +89.5%	$5.4M
Net Income	$-5.7M -21.4%	$-4.7M +32.0%	$-6.9M +20.4%	$-8.7M -27.7%	$-6.8M +7.1%	$-7.3M
Operating Income	$-5.7M +15.7%	$-6.8M +4.9%	$-7.1M +19.5%	$-8.8M -19.6%	$-7.4M +1.0%	$-7.5M
EPS (Diluted)	$-0.07 -16.7%	$-0.06	—	—	$-0.10 +16.7%	$-0.12
Total Assets	$7.8M -20.3%	$9.8M -13.8%	$11.4M -17.0%	$13.7M -30.8%	$19.8M +1.2%	$19.6M
Operating Cash Flow	$-2.9M +0.1%	$-2.9M +45.2%	$-5.3M +11.7%	$-6.0M -49.5%	$-4.0M +42.3%	$-7.0M

AI Insight: MLSS Financial Trends

MLSS remains unprofitable with stalled revenue at $2M quarterly while equity base shrinks to $2M—cash burn persists despite slight operating margin improvement.

• Operating margin improved from -100% in Q2 2024 to -50% in Q1 2026, reflecting cost discipline amid flat revenue.

• Revenue stalled at $2M/quarter since Q1 2025; no growth trajectory visible over 12-month span.

• Equity base contracted 75% from $8M (Q2 2024) to $2M (Q1 2026) due to cumulative losses.

⚠ Operating cash flow has flatlined near zero since Q3 2025; company burning equity without revenue growth.

⚠ Equity now at critical $2M level; further losses risk insolvency without capital injection or revenue inflection.

AI Insight: MLSS Ratio Trends

Operating margin inflection from -101.4% in Q4 2024 to -38.3% in Q1 2026 signals structural cost containment, but persistent unprofitability across all return metrics remains acute.

• Operating margin improved 63.1pp from Q4 2024 low of -101.4% to -38.3% in Q1 2026, showing four consecutive quarters of narrowing losses.

• Net profit margin recovered to -38.9% in Q1 2026 versus -101.1% in Q4 2024, indicating progress toward breakeven.

• ROE and ROA remain deeply negative at -147.0% and -42.2% respectively in Q1 2026, destroying shareholder capital.

⚠ Company remains unprofitable across all quarters; trajectory toward breakeven is credible but unproven in actual GAAP profitability.

⚠ ROE deteriorated further to -147.0% in Q1 2026 from -139.6% in Q4 2024, despite operating margin gains—equity base erosion risk.

Get alerted when MLSS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for MILESTONE SCIENTIFIC INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of MLSS

VANGUARD CAPITAL MANAGEMENT LLC
$572.2K1,986,648 sh
GEODE CAPITAL MANAGEMENT, LLC
$177.6K616,645 sh
VANGUARD FIDUCIARY TRUST CO
$92.6K321,583 sh
CITADEL ADVISORS LLC
$48.1K167,135 sh
STATE STREET CORP
$40.3K139,885 sh
LPL Financial LLC
$36.0K124,945 sh
Mariner, LLC
$35.1K121,750 sh
NORTHERN TRUST CORP
$32.4K112,615 sh
World Investment Advisors
$30.0K104,000 sh
Carnegie Investment Counsel
$28.9K100,175 sh

Fund	Value	Shares
VANGUARD CAPITAL MANAGEMENT LLC	$572.2K	1,986,648
GEODE CAPITAL MANAGEMENT, LLC	$177.6K	616,645
VANGUARD FIDUCIARY TRUST CO	$92.6K	321,583
CITADEL ADVISORS LLC	$48.1K	167,135
STATE STREET CORP	$40.3K	139,885
LPL Financial LLC	$36.0K	124,945
Mariner, LLC	$35.1K	121,750
NORTHERN TRUST CORP	$32.4K	112,615
World Investment Advisors	$30.0K	104,000
Carnegie Investment Counsel	$28.9K	100,175

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put MLSS on your watchlist

Track score changes the day MILESTONE SCIENTIFIC INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is MLSS a good stock to buy?

13F Pro's AI-powered analysis of MILESTONE SCIENTIFIC INC. (MLSS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MLSS are available on the MLSS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own MLSS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MLSS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MILESTONE SCIENTIFIC INC.'s investment landscape.